封面
市场调查报告书
商品编码
1767774

全球滑动染色机市场:产业分析、规模、份额、成长、趋势和预测(2025-2032 年)

Slide Stainer Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日期: | 出版商: Persistence Market Research | 英文 179 Pages | 商品交期: 2-5个工作天内

价格
简介目录

主要发现

  • 滑动染色机市场规模:47亿美元(2025年)
  • 预计市场价值:65亿美元(2032年)
  • 全球市场成长率:6.9%(2025年至2032年的复合年增长率)

滑动染色机市场报告范围

切片染色机在临床实验室、病理实验室和研究机构的组织切片和细胞学样本染色自动化过程中发挥至关重要的作用。这些仪器可确保染色品质始终如一,减少人为错误,并提高实验室工作流程效率。切片染色机市场面向医院、诊断实验室、学术研究机构和製药公司,提供一系列仪器,包括自动切片染色机、半自动化系统以及染色试剂等耗材。市场成长的驱动因素包括癌症和感染疾病病率的上升、对精准快速诊断日益增长的需求,以及染色技术的进步,这些进步提高了染色的通量和结果品质。

市场成长动力

全球切片染色机市场受多种因素驱动,其中包括病理实验室和医院对高通量诊断解决方案日益增长的需求。全球癌症和感染疾病率的上升推动了对精准组织诊断的需求,从而促进了自动化切片染色机的采用,以减少人工错误并提高可重复性。数位成像整合以及可连接实验室资讯管理系统 (LIS) 的全自动系统开发等技术进步,实现了高效的数据管理并提高了诊断准确性,进一步推动了市场扩张。此外,对个人化医疗和分子病理学日益增长的关注,刺激了对先进染色技术和多重检测的需求,为市场参与企业提供了新的成长途径。

市场限制

儘管成长前景光明,但玻片染色机市场仍面临与先进自动化系统相关的高资本投入和营运成本相关的挑战。新兴经济体的小型实验室和医疗机构可能难以负担先进的玻片染色机,从而限制了其在成本敏感地区的市场渗透。此外,诊断设备的严格监管要求,加上必须符合认证和品质标准,为製造商和医疗保健提供者带来了营运挑战。此外,试剂相容性、交叉污染和仪器维护方面的担忧构成了技术障碍,阻碍了某些最终用户的采用率。

市场机会

在技术创新、诊断能力提升以及医疗基础设施投资不断增加的推动下,切片染色机市场正迎来巨大的成长机会。切片染色机与人工智慧和数位病理平台的整合,有助于快速分析、远端会诊和优化诊断工作流程,为市场成长开闢了新的途径。此外,精准肿瘤学和伴随诊断的日益增长的关注,也推动了对免疫组织化学 (IHC) 和原位杂合反应(ISH) 等先进染色技术的需求,从而拓宽了切片染色机的应用范围。製造商、病理实验室和技术提供者之间的策略联盟,以及对经济高效、易于使用的解决方案的研发投入,对于在不断变化的诊断格局中把握新机会、保持市场领先地位至关重要。

该报告研究了全球滑动染色机市场,并对市场动态进行了详细分析,包括成长动力、趋势、机会和挑战。

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子-相关性和影响力

第三章 增值考虑

  • 产品采用分析
  • 价值链分析
  • 监管情景
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章 全球滑轨染色机市场展望

  • 主要亮点
    • 市场规模及年成长
    • 绝对的商机
  • 市场规模分析及预测
    • 市场规模表现分析(2019-2024)
    • 市场规模分析与预测(2025-2032)
  • 全球滑动染色机市场展望:产品
    • 简介/主要发现
    • 市场规模绩效分析:依产品(2019-2024 年)
    • 按产品分類的市场规模分析与预测(2025-2032)
      • 试剂
      • 装置
      • 耗材及配件
    • 市场吸引力分析:产品
  • 全球滑动染色机市场展望:应用
    • 简介/主要发现
    • 历史市场规模分析:按应用(2019-2024)
    • 按应用分類的市场规模分析和预测(2025-2032)
      • 组织学
      • 细胞学
      • 微生物学
      • 免疫组织化学
    • 市场吸引力分析:应用
  • 全球滑动染色机市场展望:最终用途
    • 简介/主要发现
    • 依最终用途分類的历史市场规模分析(2019-2024)
    • 按最终用途分類的市场规模分析和预测(2025-2032)
      • 医院
      • 诊断实验室
    • 市场吸引力分析:最终用途

第五章全球滑动染色机市场依区域展望

  • 主要亮点
  • 市场规模绩效分析:按地区(2019-2024)
  • 各地区市场规模分析及预测(2025-2032)
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析:地区

6. 北美滑动染色机市场展望

7. 欧洲滑动染色机市场展望

第八章东亚滑动染色机市场展望

9.南亚及大洋洲滑动染色机市场展望

第十章拉丁美洲滑动染色机市场展望

第十一章中东与非洲滑动染色机市场展望

第十二章竞争格局

  • 市场占有率分析(2025年)
  • 市场结构
    • 竞争强度图:按市场
    • 竞争仪錶板
  • 公司简介(详情-概述、财务状况、策略、最新发展)
    • F.Hoffman-La Roche Ltd.
    • Danaher Corporation
    • PHC Holdings Corporation
    • Thermo Fisher Scientific Inc.
    • Merck KGAA
    • Agilent Technologies, Inc.
    • Abcam Plc.
    • Becton, Dickinson and Company
    • Siemens Healthineers AG
    • BiocareMedical, LLC
    • Hardy Diagnostics
    • General Data Company
    • ELITechGroup
    • Biogenex
    • Histo-Line Laboratories
    • SLEE medical GmbH
    • Amos scientific Pty Ltd.
    • 其他的

第十三章 附录

简介目录
Product Code: PMRREP34769

Persistence Market Research has recently released a comprehensive report on the worldwide market for slide stainers. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global slide stainer market from 2025 to 2032.

Key Insights:

  • Slide Stainer Market Size (2025E): USD 4.7 Billion
  • Projected Market Value (2032F): USD 6.5 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.9%

Slide Stainer Market - Report Scope:

Slide stainers play a crucial role in clinical laboratories, pathology labs, and research institutions for automating the staining process of tissue sections and cytology samples. These devices ensure consistent staining quality, reduce human error, and enhance laboratory workflow efficiency. The slide stainer market caters to hospitals, diagnostic laboratories, academic research institutes, and pharmaceutical companies, offering a range of instruments, including automated slide stainers, semi-automated systems, and consumables such as staining reagents. Market growth is driven by the rising prevalence of cancer and infectious diseases, the increasing demand for precise and rapid diagnostics, and technological advancements in staining techniques that improve throughput and quality of results.

Market Growth Drivers:

The global slide stainer market is propelled by several key factors, including growing demand for high-throughput diagnostic solutions in pathology labs and hospitals. The rising global incidence of cancer and infectious diseases fuels the need for accurate tissue diagnostics, driving the adoption of automated slide stainers that reduce manual errors and enhance reproducibility. Technological advancements, such as the development of fully automated systems with integrated digital imaging and connectivity to laboratory information systems (LIS), enable efficient data management and improved diagnostic accuracy, further fostering market expansion. Moreover, the increasing focus on personalized medicine and molecular pathology has spurred the demand for advanced staining techniques and multiplex assays, creating new growth avenues for market participants.

Market Restraints:

Despite promising growth prospects, the slide stainer market faces challenges related to high capital investment costs and operational expenses associated with advanced automated systems. Smaller laboratories and healthcare facilities in emerging economies may struggle to afford sophisticated slide stainers, limiting market penetration in cost-sensitive regions. Furthermore, stringent regulatory requirements for diagnostic devices, coupled with the need for validation and compliance with quality standards, impose operational challenges on manufacturers and healthcare providers. Additionally, concerns regarding reagent compatibility, cross-contamination, and instrument maintenance pose technical obstacles that can hinder adoption rates among certain end users.

Market Opportunities:

The slide stainer market presents significant growth opportunities driven by technological innovations, expanding diagnostic capabilities, and increasing investment in healthcare infrastructure. The integration of artificial intelligence and digital pathology platforms with slide stainers facilitates rapid analysis, remote consultations, and enhanced diagnostic workflows, opening new avenues for market growth. Furthermore, the growing focus on precision oncology and companion diagnostics drives the demand for advanced staining techniques, including immunohistochemistry (IHC) and in situ hybridization (ISH), broadening the application scope for slide stainers. Strategic collaborations between manufacturers, pathology labs, and technology providers, along with investment in research and development for cost-effective and user-friendly solutions, are essential to capitalize on emerging opportunities and maintain market leadership in the evolving diagnostic landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the slide stainer market globally?
  • Which product types and applications are driving slide stainer adoption across different healthcare and research settings?
  • How are technological advancements reshaping the competitive landscape of the slide stainer market?
  • Who are the key players contributing to the slide stainer market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global slide stainer market?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop advanced slide staining solutions, incorporating automation, digital imaging, and software integration to enhance diagnostic accuracy and efficiency. Collaborations with healthcare providers, diagnostic laboratories, and technology companies facilitate market penetration and promote adoption of new technologies. Moreover, emphasis on customer training, after-sales support, and regulatory compliance strengthens market presence and enhances customer loyalty in the rapidly evolving slide stainer landscape.

Key Companies Profiled:

  • F.Hoffman-La Roche Ltd.
  • Danaher Corporation
  • PHC Holdings Corporation
  • Thermo Fisher Scientific Inc.
  • Merck KGAA
  • Agilent Technologies, Inc.
  • Abcam Plc.
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • BiocareMedical, LLC
  • Hardy Diagnostics
  • General Data Company
  • ELITechGroup
  • Biogenex
  • Histo-Line Laboratories
  • SLEE medical GmbH
  • Amos scientific Pty Ltd.
  • Others

Slide Stainer Market Research Segmentation:

By Product

  • Reagents
  • Equipment
  • Consumables & Accessories

By Application

  • Histology
  • Cytology
  • Microbiology
  • Immunohistochemistry

By End Use

  • Hospitals
  • Diagnostic Labs

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • Asia Pacific and Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Slide Stainer Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Value Chain Analysis
  • 3.3. Regulatory Scenario
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Slide Stainer Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Slide Stainer Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
      • 4.3.3.1. Reagents
      • 4.3.3.2. Equipment
      • 4.3.3.3. Consumables & Accessories
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global Slide Stainer Market Outlook: Application
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.3.1. Histology
      • 4.4.3.2. Cytology
      • 4.4.3.3. Microbiology
      • 4.4.3.4. Immunohistochemistry
    • 4.4.4. Market Attractiveness Analysis: Application
  • 4.5. Global Slide Stainer Market Outlook: End Use
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2019-2024
    • 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic Labs
    • 4.5.4. Market Attractiveness Analysis: End Use

5. Global Slide Stainer Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Slide Stainer Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By End Use
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 6.4.1. Reagents
    • 6.4.2. Equipment
    • 6.4.3. Consumables & Accessories
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 6.5.1. Histology
    • 6.5.2. Cytology
    • 6.5.3. Microbiology
    • 6.5.4. Immunohistochemistry
  • 6.6. Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 6.6.1. Hospitals
    • 6.6.2. Diagnostic Labs
  • 6.7. Market Attractiveness Analysis

7. Europe Slide Stainer Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End Use
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Reagents
    • 7.4.2. Equipment
    • 7.4.3. Consumables & Accessories
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Histology
    • 7.5.2. Cytology
    • 7.5.3. Microbiology
    • 7.5.4. Immunohistochemistry
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic Labs
  • 7.7. Market Attractiveness Analysis

8. East Asia Slide Stainer Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End Use
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Reagents
    • 8.4.2. Equipment
    • 8.4.3. Consumables & Accessories
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Histology
    • 8.5.2. Cytology
    • 8.5.3. Microbiology
    • 8.5.4. Immunohistochemistry
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic Labs
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Slide Stainer Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End Use
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Reagents
    • 9.4.2. Equipment
    • 9.4.3. Consumables & Accessories
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Histology
    • 9.5.2. Cytology
    • 9.5.3. Microbiology
    • 9.5.4. Immunohistochemistry
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Labs
  • 9.7. Market Attractiveness Analysis

10. Latin America Slide Stainer Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End Use
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Reagents
    • 10.4.2. Equipment
    • 10.4.3. Consumables & Accessories
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Histology
    • 10.5.2. Cytology
    • 10.5.3. Microbiology
    • 10.5.4. Immunohistochemistry
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Labs
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Slide Stainer Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End Use
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Reagents
    • 11.4.2. Equipment
    • 11.4.3. Consumables & Accessories
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Histology
    • 11.5.2. Cytology
    • 11.5.3. Microbiology
    • 11.5.4. Immunohistochemistry
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Labs
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. F.Hoffman-La Roche Ltd.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Danaher Corporation
    • 12.3.3. PHC Holdings Corporation
    • 12.3.4. Thermo Fisher Scientific Inc.
    • 12.3.5. Merck KGAA
    • 12.3.6. Agilent Technologies, Inc.
    • 12.3.7. Abcam Plc.
    • 12.3.8. Becton, Dickinson and Company
    • 12.3.9. Siemens Healthineers AG
    • 12.3.10. BiocareMedical, LLC
    • 12.3.11. Hardy Diagnostics
    • 12.3.12. General Data Company
    • 12.3.13. ELITechGroup
    • 12.3.14. Biogenex
    • 12.3.15. Histo-Line Laboratories
    • 12.3.16. SLEE medical GmbH
    • 12.3.17. Amos scientific Pty Ltd.
    • 12.3.18. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations